Gane E. Safety and Efficacy at 1 year after Switching from Tenofovir Disoproxil Fumurate to Tenofovir Alafenamide in Chronic HBV Patients with Risk Factors for TDF Use. PS-156.
ID Week: highlights uit de Late Breaker-sessies
okt 2021 | Bacteriële infecties, HIV, Tuberculose, Vaccinatie, Virale infecties